Stamper B, Chaturvedi K, Avula B, Bae J, Wang Y, Bledsoe K
Metabolites. 2025; 15(2).
PMID: 39997694
PMC: 11857573.
DOI: 10.3390/metabo15020069.
Gambaro E, Gramaglia C, Cenci D, Ferrante D, Gavelli F, Bellan M
Int J Environ Res Public Health. 2025; 22(1).
PMID: 39857476
PMC: 11764999.
DOI: 10.3390/ijerph22010023.
Sharma A, Tyagi P, Khumallambam M, Tyagi M
Cells. 2024; 13(23).
PMID: 39682697
PMC: 11640508.
DOI: 10.3390/cells13231950.
Sharma A, Tyagi P, Khumallambam M, Tyagi M
bioRxiv. 2024; .
PMID: 39229050
PMC: 11370412.
DOI: 10.1101/2024.08.19.608673.
Li Y, Wang X, Meng Y, Hu T, Zhao J, Li R
Nature. 2024; 632(8025):686-694.
PMID: 39112701
DOI: 10.1038/s41586-024-07796-0.
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.
J Addict Med. 2024; 18(1S Suppl 1):1-56.
PMID: 38669101
PMC: 11105801.
DOI: 10.1097/ADM.0000000000001299.
Cannabis donation as a harm reduction strategy: a case study.
Clarke S, Victor G, Lynch P, Suen L, Ray B
Harm Reduct J. 2024; 21(1):58.
PMID: 38449029
PMC: 10916026.
DOI: 10.1186/s12954-024-00974-3.
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.
Wouldes T, Lester B
Front Pediatr. 2024; 11:1305508.
PMID: 38250592
PMC: 10798256.
DOI: 10.3389/fped.2023.1305508.
Housing Instability Associated with Return to Stimulant Use among Previously Abstaining Women.
Mehtani N, Chuku C, Meacham M, Vittinghoff E, Dilworth S, Riley E
Int J Environ Res Public Health. 2023; 20(19).
PMID: 37835100
PMC: 10572661.
DOI: 10.3390/ijerph20196830.
Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder.
Khan D, Behaeddin B, Uhlyar S, Parker J
Cureus. 2023; 15(4):e37700.
PMID: 37206494
PMC: 10191240.
DOI: 10.7759/cureus.37700.
Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021.
Pickens C, Jones C, Guy Jr G, Govoni T, Green J
Drug Alcohol Depend Rep. 2023; 7:100153.
PMID: 37123433
PMC: 10133667.
DOI: 10.1016/j.dadr.2023.100153.
Therapeutic Efficiency of Humic Acids in Intoxications.
Vaskova J, Stupak M, Vidova Ugurbas M, Zatko D, Vasko L
Life (Basel). 2023; 13(4).
PMID: 37109500
PMC: 10143271.
DOI: 10.3390/life13040971.
Trends in cocaine and crystal methamphetamine injection over time in a Canadian setting between 2008 and 2018.
Bach P, Ti L, Hayashi K, Cui Z, Milloy M, Fairbairn N
J Subst Use Addict Treat. 2023; 151:208982.
PMID: 36848997
PMC: 10805263.
DOI: 10.1016/j.josat.2023.208982.
Association of prescribed oral stimulants on cocaine use among patients enrolled in opioid agonist treatment: A retrospective longitudinal cohort study.
Tatangelo M, Tahsin F, Morin K, Marsh D
Front Psychiatry. 2022; 13:1074691.
PMID: 36532164
PMC: 9755664.
DOI: 10.3389/fpsyt.2022.1074691.
Association of Polymorphism within the Putative miRNA Target Site in the 3'UTR Region of the Gene with Neuroticism in Patients with Substance Use Disorder.
Boron A, Smiarowska M, Grzywacz A, Chmielowiec K, Chmielowiec J, Masiak J
Int J Environ Res Public Health. 2022; 19(16).
PMID: 36011589
PMC: 9408599.
DOI: 10.3390/ijerph19169955.
The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?.
Hoj S, Minoyan N, Artenie A, Grebely J, Bruneau J
Can Liver J. 2022; 1(2):4-13.
PMID: 35990720
PMC: 9202798.
DOI: 10.3138/canlivj.1.2.003.
Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model.
Peer-Nissan H, Ahdoot-Levi H, Betzer O, Shirel Itzhak P, Shraga-Heled N, Gispan I
Pharmaceutics. 2022; 14(7).
PMID: 35890207
PMC: 9324501.
DOI: 10.3390/pharmaceutics14071311.
Addressing Methamphetamine Use in Primary Care: Provider Perspectives.
Dunn J, Yuan M, Ramirez F, Garneau H, Brown-Johnson C, Breland H
J Addict Med. 2022; 17(1):60-66.
PMID: 35841323
PMC: 9897271.
DOI: 10.1097/ADM.0000000000001035.
Effects of resilience on impulsivity, cognition and depression during protracted withdrawal among Chinese male methamphetamine users.
He H, Zhou S, Peng C, Ran W, Tong S, Hong L
BMC Psychiatry. 2022; 22(1):414.
PMID: 35729547
PMC: 9215047.
DOI: 10.1186/s12888-022-04041-8.
Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
Corser J, Palis H, Fleury M, Lamb J, Lock K, McDougall J
Harm Reduct J. 2022; 19(1):46.
PMID: 35590375
PMC: 9118627.
DOI: 10.1186/s12954-022-00630-8.